Gentian AS is headquartered in Moss, Norway, with representation in China and USA. Gentian´s employees (31 persons of varied age and nationality) develop, produce and market highly-sensitive diagnostic reagents and methods for the global clinical laboratory market, both human and veterinary. Gentian´s products have gained substantial market share due to their high quality from utilizing our proprietary technology for nanoparticle enhanced diagnostic tests. Our export rate is 99%. Gentian coordinates several well-funded international R&D projects partnered by leading clinical and commercial organizations using nanoparticle-based technologies invented and owned by Gentian. A number of exciting and original diagnostic products are in the pipeline, and new employment opportunities are being created.
production, IVD, QC, quality, qa